Casdin Capital Founded 2012
Founders Eli Casdin
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 48
Average round size
info
The average size of a deal this fund participated in
$106M
Portfolio companies 48
Rounds per year 5.33
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Financial Services
Life Science
Summary

Casdin Capital appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the New York. The company was established in North America in United States.

The fund is constantly included in 2-6 investment rounds annually. This Casdin Capital works on 13 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. The typical startup value when the investment from Casdin Capital is more than 1 billion dollars.

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Casdin Capital, startups are often financed by The Column Group, ARCH Venture Partners, Topspin Partners. The meaningful sponsors for the fund in investment in the same round are Foresite Capital, Redmile Group, Wellington Management. In the next rounds fund is usually obtained by Redmile Group, Perceptive Advisors, GV.

We also calculated 2 valuable employees in our database.

The fund has no exact preference in some founders of portfolio startups. When startup sums 1 of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Foundation Medicine, Flatiron Health, 23andMe. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
EQRx
Biotechnology
Health Care
Medical
Pharmaceutical
Series B
500M11 Jan 2021 United Kingdom, Cambridge
EQRx
Biotechnology
Health Care
Medical
Pharmaceutical
Series A
200M12 Jan 2020 United Kingdom, Cambridge
4D Molecular Therapeutics
Biotechnology
Drug Discovery
Genetics
Series C
75M16 Jun 2020 United States, Emeryville
Genome Medical
Genetics
Health Care
Life Science
Medical
Series B
23M11 Jun 2019 United States, South San Francisco
Tango Therapeutics
Biotechnology
Health Care
Medical
Therapeutics
Venture - Series Unknown
50M17 Aug 2020 United Kingdom, Cambridge
908 Devices
Battery
Chemical
Hardware
Manufacturing
Series D
20M15 Mar 2017 United Kingdom, Boston
Invitae
Biotechnology
Genetics
Health Care
Series E
40M10 Dec 2013 Panama, San Francisco
Variant Bio
Biotechnology
Series A
24M10 Oct 2019 United States, Seattle
Kronos Bio
Biotechnology
Chemical
Therapeutics
Private Equity
155M25 Aug 2020
Lyra Health
Employee Benefits
Health Care
Information Services
Information Technology
Series D
110M25 Aug 2020 United States, Burlingame
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Casdin Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: